ovarian cancer

Research

Machine learning to hone precision meds for cancer backup genes

Researchers have used machine learning to identify cancer cells' backup genes and add context that could make precision medicines more precise.
Helen Floersh Sep 29, 2022 3:30pm

IMV drops 3rd of staff in refocus on lead oncology asset

Sep 15, 2022 9:45am

ESMO: Data boosts Regeneron's plans to 'take on' ovarian cancer

Sep 12, 2022 10:10am

VBL lays off 35% of staff after failure-induced stock shock

Aug 2, 2022 11:03am

Panic infects VBL investors as therapy fails phase 3 cancer test

Jul 20, 2022 6:30am

Roche pays Repare $125M to join Big Pharma peers in cancer race

Jun 2, 2022 8:27am